Ligand Pharmaceuticals In shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.0M | 11k | 177.14 |
| 2025-06-30 | $1.3M | 11k | 113.68 |
| 2025-03-31 | $1.1M | 10k | 105.14 |
| 2024-12-31 | $1.1M | 11k | 107.15 |
| 2024-09-30 | $995k | 9.9k | 100.09 |
| 2024-06-30 | $838k | 9.9k | 84.26 |
| 2023-12-31 | $628k | 8.8k | 71.42 |
| 2023-09-30 | $527k | 8.8k | 59.92 |
| 2023-06-30 | $634k | 8.8k | 72.10 |
| 2023-03-31 | $596k | 8.1k | 73.56 |
| 2022-12-31 | $576k | 8.6k | 66.80 |
| 2022-09-30 | $742k | 8.6k | 86.11 |
| 2022-06-30 | $769k | 8.6k | 89.22 |
| 2022-03-31 | $969k | 8.6k | 112.45 |
| 2021-12-31 | $859k | 5.6k | 154.39 |
| 2021-09-30 | $775k | 5.6k | 139.32 |
| 2021-06-30 | $1.8M | 14k | 131.19 |
| 2021-03-31 | $2.2M | 14k | 152.45 |
| 2020-12-31 | $1.5M | 15k | 99.45 |
| 2020-09-30 | $1.5M | 16k | 95.32 |
| 2020-06-30 | $1.8M | 16k | 111.83 |
| 2020-03-31 | $1.2M | 17k | 72.72 |
| 2019-12-31 | $1.8M | 18k | 104.28 |
| 2019-09-30 | $1.9M | 20k | 99.54 |
| 2019-06-30 | $2.4M | 21k | 114.15 |
| 2019-03-31 | $2.7M | 22k | 125.71 |
| 2018-12-31 | $3.0M | 22k | 135.70 |
| 2018-09-30 | $4.0M | 15k | 274.51 |
| 2018-06-30 | $1.9M | 9.3k | 207.16 |
| 2018-03-31 | $1.5M | 9.3k | 165.15 |
| 2017-12-31 | $1.3M | 9.3k | 136.96 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors